BioCentury
ARTICLE | Clinical News

18-methoxycoronaridine: Phase I started

October 13, 2014 7:00 AM UTC

Savant said partner Hebron Farmaceutica began a double-blind, placebo-controlled, Brazilian Phase I trial to evaluate oral 18-MC in healthy volunteers. Hebron is developing the compound outside of Nor...